Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs McDonald's Corp (MCD) Price & Performance

Adaptive Biotechnologies CorpTrade
McDonald's CorpTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs McDonald's Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while McDonald's Corp trades at $274 (market cap $194.00B). The key difference: McDonald's Corp is far larger — about 48× Adaptive Biotechnologies Corp's market cap, and McDonald's Corp pays a 2.71% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTMCD
Market Cap
$4.04B$194.00B
Sector
HealthConsumer Cyclical
52-Week High
$25.45$341.06
52-Week Low
$12.30$262.80
Enterprise Value
$4.10B$247.77B
Volume
2,230,036
Dividend Yield
2.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Adaptive Biotechnologies Corp

No Aura AI signal available yet.

McDonald's Corp

McDonald's (MCD) trades at $274.15, down slightly by 0.12% on the day, with technical indicators showing a neutral overall signal. The company demonstrates strong fundamentals with consistent revenue growth, reaching $26.89 billion in 2025, and robust profitability with a 31.72% net income margin. Recent earnings have consistently beaten expectations, and the company has announced a new global growth strategy focused on automation and menu innovation to drive future performance.

The outlook for MCD is positive, supported by strong analyst consensus with a $322.45 price target implying significant upside. Key opportunities include the successful execution of its new growth plan and its defensive qualities in a challenging economy. Primary risks involve inflationary pressures on franchisee margins and intense competition in the quick-service restaurant sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About McDonald's Corp

McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.

Read more on MCD